NCT01675310

Medical Nutrition Therapy Plus Transgestational Metformin For Preventing Gestational Diabetes In High Risk Mexican Women

EFFECTIVITY OF MEDICAL NUTRITION THERAPY PLUS TRANSGESTATIONAL METFORMIN FOR PREVENTING THE INCIDENCE OF GESTATIONAL DIABETES MELLITUS IN HIGH RISK MEXICAN WOMEN.

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 90 (actual)
• Sponsor: Instituto Nacional de Perinatologia Isidro Espinosa de los Reyes · Other Government
• Sex: Female
• Age: 18 Years – 50 Years
• Healthy volunteers: Not accepted

Summary

Gestational diabetes mellitus is one of the most frequent complications of pregnancy, that affect between 1 to 14% of population around the world. There is a few studies to prevent gestational diabetes mellitus in high risk women as Mexican population. Metformin has been used during pregnancy in women with gestational diabetes and women with polycystic ovary syndrome, with acceptable security for mother and fetus. Metformin decrease the insulin resistance and weight gain, we believe that metformin may be decrease the risk of gestational diabetes mellitus in high risk women.

Conditions

• Pregestational Obesity (BMI > 27kg/m2)
• History of Polycystic Ovary Syndrome

Interventions

Type	Name	Description
DRUG	medical nutrition therapy + metformin
BEHAVIORAL	Medical nutrition therapy	medical nutrition therapy

Timeline

• Start date: 2012-01-01
• Primary completion: 2014-12-01
• Completion: 2015-03-01
• First posted: 2012-08-29
• Last updated: 2015-03-25

Locations

1 site across 1 country: Mexico